bromouracil has been researched along with Malignant Melanoma in 1 studies
Bromouracil: 5-Bromo-2,4(1H,3H)-pyrimidinedione. Brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA. It is used mainly as an experimental mutagen, but its deoxyriboside (BROMODEOXYURIDINE) is used to treat neoplasms.
5-bromouracil : A pyrimidine having keto groups at the 2- and 4-positions and a bromo group at the 5-position. Used mainly as an experimental mutagen.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotani, H | 1 |
| Butler, G | 1 |
| Heggan, D | 1 |
| McGarrity, GJ | 1 |
1 other study available for bromouracil and Malignant Melanoma
| Article | Year |
|---|---|
Elimination of mycoplasmas from cell cultures by a novel soft agar technique.
Topics: Agar; Animals; Bromouracil; Cells, Cultured; Fibroblasts; Humans; Lymphocytes; Lymphoma; Melanoma; M | 1991 |